Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I bioequivalence study of new enarodustat formulation
jRCT2071210099Phase 1Completed
- Sponsor
- Japan Tobacco
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of enarodustat in anemia of renal disease (2 arms), sponsored by Japan Tobacco. Primary endpoint: Primary pharmacokinetic endpoint. Started Dec 2021; status: completed.
02
Drugs
enarodustat
03
Conditions
anemia of renal disease
Beyond the preview
Go deeper on jRCT2071210099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071210099.